PMS21 COST-EFFECTIVENESS OF RITUXIMAB VS ADALIMUMAB IN THE TREATMENT OF MODERATE TO SEVERE RHEUMATOID ARTHRITIS
May 1, 2010, 00:00
10.1016/S1098-3015(10)72609-7
https://www.valueinhealthjournal.com/article/S1098-3015(10)72609-7/fulltext
Title :
PMS21 COST-EFFECTIVENESS OF RITUXIMAB VS ADALIMUMAB IN THE TREATMENT OF MODERATE TO SEVERE RHEUMATOID ARTHRITIS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)72609-7&doi=10.1016/S1098-3015(10)72609-7
First page :
Section Title :
Open access? :
No
Section Order :
150